141 related articles for article (PubMed ID: 19011337)
1. [Feasibility of peripheral vein during FOLFOX/FOLFIRI chemotherapy through peripheral venous system].
Kimura T; Iwase K; Aono T; Nakai S; Fujii M; Nishikawa K; Matsuda C; Shimada K; Hirota M; Nasu S; Wada D; Hasegawa J; Tanaka Y
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1889-94. PubMed ID: 19011337
[TBL] [Abstract][Full Text] [Related]
2. [Report of a case effectively treated by appropriate therapy for severe anticipatory nausea and vomiting due to FOLFOX or FOLFIRI].
Mori M; Kiba T; Oikawa M; Hokkoku K; Watanabe Y; Nakagawa T; Shintaku K; Yoshimitsu Y; Sakuma H; Ueda H; Nakai M
Gan To Kagaku Ryoho; 2009 Feb; 36(2):325-7. PubMed ID: 19223757
[TBL] [Abstract][Full Text] [Related]
3. Central venous access port-related complications in outpatient chemotherapy for colorectal cancer.
Inaba Y; Yamaura H; Sato Y; Najima M; Shimamoto H; Nishiofuku H; Ura T; Muro K
Jpn J Clin Oncol; 2007 Dec; 37(12):951-4. PubMed ID: 18057011
[TBL] [Abstract][Full Text] [Related]
4. [Results of neo-adjuvant chemotherapy by FOLFOX and FOLFIRI for colorectal liver metastasis].
Amano R; Yamada N; Noda E; Kubo N; Tanaka H; Muguruma K; Inoue T; Yashiro M; Maeda K; Onoda N; Sawada T; Nakata B; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2003-5. PubMed ID: 20037305
[TBL] [Abstract][Full Text] [Related]
5. [Outpatient chemotherapy of an advanced or metastatic colorectal cancer].
Sato T; Kokuba Y; Ozawa H; Hatate K; Nakamura T; Onosato W; Ihara A; Watanabe M
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():257-9. PubMed ID: 17469353
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
7. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
[TBL] [Abstract][Full Text] [Related]
8. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
[TBL] [Abstract][Full Text] [Related]
9. [Survey on the compliance of patients with continuous infusion of 5-fluorouracil via portable infusion pumps].
Sato J; Terui K; Awatsu A; Koyama M; Itoh J; Saijo Y; Hayakari M
Gan To Kagaku Ryoho; 2010 Apr; 37(4):671-5. PubMed ID: 20414024
[TBL] [Abstract][Full Text] [Related]
10. Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study.
Zaanan A; Gauthier M; Malka D; Locher C; Gornet JM; Thirot-Bidault A; Tougeron D; Taïeb J; Bonnetain F; Aparicio T;
Cancer; 2011 Apr; 117(7):1422-8. PubMed ID: 21425142
[TBL] [Abstract][Full Text] [Related]
11. [Development of taste disorders following FOLFOX-FOLFIRI therapy and its effects on the QOL of patients with colorectal cancer].
Takimoto N; Sugawara S; Iida A; Sakakibara T; Mori K; Sugiura M; Yamamura K; Adachi M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):431-5. PubMed ID: 19295267
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and Safety of FOLFIRI after Failure of FOLFOX-4 in Advanced Gastric Cancer].
Kwon HJ; Park MI; Park SJ; Moon W; Kim SE; Lee HW; Choi YJ; Kim JH
Korean J Gastroenterol; 2015 Jul; 66(1):10-6. PubMed ID: 26194124
[TBL] [Abstract][Full Text] [Related]
13. Central venous port system-related complications in outpatient chemotherapy for colorectal cancer.
Tsutsumi S; Fukasawa T; Fujii T; Tabe Y; Kigure W; Asao T; Kuwano H
Hepatogastroenterology; 2012 Jun; 59(116):1079-80. PubMed ID: 22580658
[TBL] [Abstract][Full Text] [Related]
14. [FOLFOX].
Mishima H; Ikenaga M; Tsujinaka T; Yasui M; Kashiwazaki M; Miyazaki M; Hirao M; Fujitani K; Nakamori S
Gan To Kagaku Ryoho; 2006 Jul; 33(7):911-4. PubMed ID: 16835479
[TBL] [Abstract][Full Text] [Related]
15. [A case of recurrent colon cancer involved in multiple organs maintaining complete response over the long-term after chemotherapy].
Hamada T; Taniguchi E; Ohta K; Yoshikawa M; Yamagami Y; Ohashi S
Gan To Kagaku Ryoho; 2013 Feb; 40(2):249-53. PubMed ID: 23411966
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of a brochure for patients undergoing FOLFIRI chemotherapy based on survey of adverse reactions].
Kamisugi K; Matsusaka S; Imada H; Shoji D; Nakamoto E; Yokokawa T; Kawakami K; Hirata Y; Nawano K; Ogawa M; Shinozaki E; Suenaga M; Mizunuma N; Hatake K; Hama T
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1331-5. PubMed ID: 18701844
[TBL] [Abstract][Full Text] [Related]
17. [Safety and efficacy of FOLFOX and FOLFIRI in elderly patients with colorectal cancer].
Mishima H; Ikenaga M; Yasui M
Nihon Rinsho; 2011 Apr; 69 Suppl 3():554-8. PubMed ID: 22214022
[No Abstract] [Full Text] [Related]
18. [The future of chemotherapy at home--from outpatient chemotherapy to chemotherapy at home].
Takahashi K
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():279-81. PubMed ID: 17469360
[TBL] [Abstract][Full Text] [Related]
19. A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma.
Catania C; Pelosi G; Fazio N; Biffi R; Spitaleri G; Noberasco C; Zampino MG; Maggioni A; Trifirò G; Toffalorio F; Vigna PD; De Braud F; De Pas T
Acta Oncol; 2010; 49(1):120-1. PubMed ID: 20100147
[No Abstract] [Full Text] [Related]
20. [A case of metastatic rectal cancer showing a sustained complete response to chemotherapy with FOLFIRI followed by UFT].
Tashima R; Yokoyama S; Yamashita Y; Baba K; Matsuda M
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1663-6. PubMed ID: 17940386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
